TGF-β1 Protein Expression in Non-Small Cell Lung Cancers is Correlated with Prognosis
Authors:
- Shu-Guang LiuSLShu-Guang Liu
- Wen-Juan QiWQWen-Juan Qi
- Yun-Fei ZhaoYZYun-Fei Zhao
- Yu-Mei LiYLYu-Mei Li
- Bin LeiBLBin Lei
- Wen-Jie ShengWSWen-Jie Sheng
- Hong ShenHSHong Shen
Open Access
- 23 October 2014
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (19) , 8143-8147
Abstract
TGF-β1 Protein Expression in Non-Small Cell Lung Cancers is Correlated with Prognosis NSCLC;transforming growth factor ${\beta}1$;quantitative analysis;prognosis; To investigate the expression intensity and prognostic significance of TGF-${\beta}1$ protein in non-small cell lung cancer (NSCLC), immunohistochemistry was carried out in 194 cases of NSCLC and 24 cases of normal lung tissues by SP methods. The PU (positive unit) value was used to assess the TGF-${\beta}1$ protein expression in systematically selected fields under the microscope with Leica Q500MC image analysis. We found that the TGF-${\beta}1$ PU value was nearly two-fold higher in NSCLC than in normal lung tissues (p=0.000), being associated with TNM stages (p=0.000) and lymph node metastases (p=0.000), but not to patient age, gender, smoking history, tumor differentiation, histological subtype and tumor location (P>0.05). Univariate analysis indicated that patients with high TGF-${\beta}1$ protein expression and lymph node metastases demonstrated a poor prognosis (both p=0.000,). Multivariate analysis showed that TGF-${\beta}1$ protein expression (RR = 2.565, p=0.002) and lymph node metastases (RR=1.874, p=0.030) were also independent prognostic factors. Thus, TGF-${\beta}1$ protein expression may be correlated to oncogenesis and serve as an independent prognostic biomarker for NSCLC.
Keywords
This publication has 25 references indexed in Scilit:
- Quantitative analysis of EZH2 expression and its correlations with lung cancer patients’ clinical pathological characteristicsClinical and Translational Oncology, 2012
- Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathwaysMolecular Biology Reports, 2011
- Transforming growth factor-beta (TGF-β) and brain tumoursJournal of Clinical Neuroscience, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Cytostatic and apoptotic actions of TGF-β in homeostasis and cancerNature Reviews Cancer, 2003
- Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasisJournal of Cell Biology, 2002
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancersOncogene, 2000
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma.Journal of Clinical Pathology, 1994